Variable | N | Control | N | APEP | N | Co-ef | Unadjusted | p | N | Adjusted | p |
---|---|---|---|---|---|---|---|---|---|---|---|
LOS (bed nights) | 94 | 970 | 95 | 880 | 199 | HR | 1.09 (0.77–1.56) | 0.6 | 125 | 1.3 (0.9–1.87) | 0.16 |
Steps median [IQR] | 23 | 597 [346–846] | 25 | 889 [575–1088] | 48 | β | 262.1 (−80–604) | 0.1 | 48 | 316 (−25–656) | 0.07 |
SPPB Score Discharge m (±SD) | 89 | 3.7 (±2.1) | 86 | 4.6 (±2.5) | 178 | β | 0.88 (0.20–1.57) | 0.01 | 174 | 0.78 (0.28–1.29) | 0.003 |
SPPB Score Follow-up m (±SD) | 52 | 4.7 (±2.53) | 72 | 5.12 (±2.38) | 123 | β | 0.45 (−0.43–1.33) | 0.3 | 122 | 0.67 (−0.74–0.87) | 0.87 |
VAS SR Health Discharge m (±SD) | 89 | 62.4(±21.31) | 86 | 67.7 (±18.38) | 178 | β | 5.3 (−0.6–1.11) | 0.07 | 172 | 5.10 (− 0.78–10.98) | 0.9 |
VAS SR Health Follow-up m (±SD) | 68 | 58.5 (±21.6) | 77 | 65.2 (±21.2) | 145 | β | 6.75 (0.3–13.8) | 0.05 | 143 | 0.26 (0.09–0.47) | 0.004 |
READMISSION Follow-up | 94 | 16 (17%) | 95 | 30 (32%) | 176 | β | 2.2 (1.1–4.3) | 0.03 | 172 | 2.9 (1.18–5.2) | 0.01 |
FALLS Follow-up | 68 | 18 (26%) | 77 | 12 (16%) | 189 | OR | 0.6 (0.26–1.36) | 0.2 | 184 | 0.57 (0.24–1.38) | 0.2 |
DEATH Follow-up | 94 | 12 (19%) | 95 | 5 (5%) | 189 | OR | 0. 40 (0.13–1.16) | 0.08 | 184 | 0.38 (0.11–1.14) | 0.08 |
IND Follow-up | 68 | 44 (65%) | 77 | 58 (75%) | 167 | OR | 1.68 (1. – 3.3) | 0.04 | 165 | 1.85 (0.82–3.6) | 0.05 |
NEGATIVE EVENTS Follow-up | 94 | 38 (40%) | 95 | 18 (19%) | 189 | OR | 0.46 (0.23–0.92) | 0.03 | 184 | 0.43 (0.2–0.92) | 0.03 |